scPharmaceuticals Inc. (SCPH) NASDAQ
$5.10 -0.01 (-0.20%)
Market Cap: $139.59M
As of 05/25/22 04:30 PM EDT. Market closed.
scPharmaceuticals Inc. (SCPH) NASDAQ
$5.10 -0.01 (-0.20%)
Market Cap: $139.59M
As of 05/25/22 04:30 PM EDT. Market closed.
scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company's lead programs focus on the ... read more
scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company's lead programs focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. read less
Open in:
Open in:
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| 5AM Partners IV, LLC | 10% Owner | Apr 11, 2022 | Sale | $5.00 | 40,733 | 203,665 | 537,301 | Apr 13, 2022, 04:51 PM |
| 5AM Partners IV, LLC | 10% Owner | Apr 11, 2022 | Sale | $5.00 | 9,171 | 45,855 | 120,966 | Apr 13, 2022, 04:51 PM |
| 5AM Partners IV, LLC | 10% Owner | Apr 11, 2022 | Sale | $5.00 | 220,096 | 1,100,480 | 2,903,207 | Apr 13, 2022, 04:51 PM |
| Khattar Jack A. | Director | Dec 03, 2021 | Buy | $3.91 | 5,000 | 19,569 | 5,000 | Dec 06, 2021, 05:55 PM |
| Tucker John H | President and CEO | Dec 03, 2021 | Buy | $3.96 | 10,000 | 39,553 | 46,962 | Dec 06, 2021, 05:53 PM |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Mar 12, 2021 | Sale | $7.22 | 39,469 | 284,816 | 2,838,034 | Mar 16, 2021, 04:30 PM |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Mar 15, 2021 | Sale | $7.03 | 110,588 | 777,787 | 2,727,446 | Mar 16, 2021, 04:30 PM |
| Tucker John H | President and CEO | Jun 30, 2020 | Option Exercise | $7.36 | 10,288 | 75,720 | 36,962 | Jul 02, 2020, 12:00 AM |
| Schwab Andrew J. | 10% Owner | May 26, 2020 | Buy | $8.65 | 578,034 | 4,999,994 | 578,034 | May 28, 2020, 09:12 PM |
| ORBIMED ADVISORS LLC | 10% Owner | May 21, 2020 | Buy | $8.65 | 1,387,283 | 11,999,997 | 4,565,948 | May 26, 2020, 04:44 PM |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Feb 14, 2020 | Buy | $8.20 | 271,993 | 2,230,343 | 3,518,998 | Feb 21, 2020, 04:46 PM |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Feb 14, 2020 | Buy | $8.20 | 271,993 | 2,230,343 | 3,247,005 | Feb 19, 2020, 12:00 AM |
| Tucker John H | President and CEO | Dec 13, 2019 | Buy | $5.24 | 5,000 | 26,188 | 5,000 | Dec 17, 2019, 04:16 PM |
| RA CAPITAL MANAGEMENT, LLC | 10% Owner | Apr 11, 2019 | Buy | $2.70 | 389,862 | 1,052,627 | 3,247,005 | Apr 15, 2019, 04:31 PM |
| Agger Mette Kirstine | Director | Nov 21, 2017 | Buy | $14.00 | 654,762 | 9,166,668 | 3,183,986 | Feb 13, 2018, 05:38 PM |
| SCHAEFFER LEONARD D | Director | Dec 19, 2017 | Option Exercise | $1.66 | 22,631 | 37,567 | 57,449 | Dec 20, 2017, 04:18 PM |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 10% Owner | Nov 21, 2017 | Buy | $14.00 | 357,143 | 5,000,002 | 357,143 | Nov 24, 2017, 04:33 PM |
| Lundbeckfond Invest A/S | 10% Owner | Nov 21, 2017 | Buy | $14.00 | 654,762 | 9,166,668 | 3,183,986 | Nov 21, 2017, 07:24 PM |
| 5AM Partners IV, LLC | 10% Owner | Nov 21, 2017 | Buy | $14.00 | 26,190 | 366,660 | 130,135 | Nov 21, 2017, 07:16 PM |
| 5AM Partners IV, LLC | 10% Owner | Nov 21, 2017 | Buy | $14.00 | 628,572 | 8,800,008 | 3,123,302 | Nov 21, 2017, 07:16 PM |
| ORBIMED ADVISORS LLC | 10% Owner | Nov 21, 2017 | Buy | $14.00 | 833,333 | 11,666,662 | 3,409,865 | Nov 21, 2017, 07:13 PM |
Period of Report: 12/31/2021
10-K/10-Q Filings: View